360 filings
Page 14 of 18
8-K
7tmxpeaz
13 Apr 10
Dynavax Raises $44 Million Through Public Offering
12:00am
8-K
tmokx2w
6 Apr 10
Other Events
12:00am
8-K
pxwkvj9 ua
25 Mar 10
Comparable safety profile to approved commercial vaccine; no evidence for increased risk of autoimmunity
12:00am
8-K
94ua prgpm
16 Mar 10
Dynavax and Merck Agree on Final Reimbursements
12:00am
8-K
9nf99vxncp6ve6q
25 Feb 10
Departure of Directors or Certain Officers
12:00am
8-K
xn3mdsqsy4um6af0
25 Feb 10
Other Events
12:00am
8-K
4ol6woy5fibtlw2uh0
18 Feb 10
Other Events
12:00am
8-K
sh80q
17 Feb 10
Dynavax Receives Canadian Approval to Conduct Phase 3 Trials of HEPLISAVTM
12:00am
8-K
1divsbkqx7t9baq
8 Feb 10
Other Events
12:00am
8-K
asml czdt
26 Jan 10
Other Events
12:00am
8-K
seg9nmaeydh4hga
4 Jan 10
Dynavax Completes Symphony Dynamo Acquisition
12:00am
8-K
xp4lghmk5 q6bst7f3
10 Dec 09
Dynavax’s European Manufacturing Facility Approved for Commercial Production of
12:00am
8-K
ljnm6
19 Nov 09
Other Events
12:00am
8-K
n5uh9aulf woozgo
10 Nov 09
Dynavax to Acquire Symphony Dynamo, Inc., Including
12:00am
8-K
ducar
5 Nov 09
Dynavax Appoints Francis R. Cano, PH.D. to Board of Directors
12:00am
8-K
c7lcdm613nusq1r9
29 Oct 09
Other Events
12:00am
8-K
cmogl26 pp7q1
23 Oct 09
Dynavax Announces Third Quarter 2009 Financial Results
12:00am
8-K
wrrw8c yjn0x54ku2p
29 Sep 09
Other Events
12:00am
8-K
cv5qb4nmyh ct44u4
11 Sep 09
Entry into a Material Definitive Agreement
12:00am
8-K
mc3o7snoffqbxdg8
20 Aug 09
Departure of Directors or Certain Officers
12:00am